XTALPI (02228) saw its stock price plummet by 5.37% in early trading on Friday, following the company's announcement of a significant share placement plan. The sharp decline came as investors reacted to the potential dilution of existing shareholdings.

Before the market opened, XTALPI revealed its intention to place up to approximately 285.9 million new shares at HK$9.28 per share. The placement, if fully subscribed, is expected to raise net proceeds of around HK$2.63 billion. The company stated that the funds would be used for various purposes, including product iteration and upgrades, enhancing research and development capabilities, product commercialization, business development, potential acquisitions and investments, talent attraction, and working capital supplementation.

The market's negative reaction to the news likely stems from concerns over share dilution and the pricing of the new shares. The placement price of HK$9.28 represents a discount to the stock's previous closing price, which may have contributed to the downward pressure on XTALPI's shares. While the company aims to use the proceeds for growth and development, investors appear to be weighing the short-term impact of the share dilution against the potential long-term benefits of the capital raise.